On June 2, Wedbush analyst Liana Moussatos published a list of upcoming catalysts for emerging pharmaceuticals, specifically for Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Receptos …
Omeros Corporation (NASDAQ:OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for both large-market as well as orphan …
Omeros Corporation (NASDAQ:OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics for large-market as well as orphan indications …
Omeros Corporation (NASDAQ:OMER) announced that the presiding European regulatory authority has approved the company’s investigational product OMS721 for compassionate use. OMS721 is Omeros’ …
In a research report issued today, MLV analyst Raghuram Selvaraju reiterated a Buy rating on Omeros Corporation (NASDAQ:OMER) with a price target of $38, after the company …
Omeros Corporation (NASDAQ:OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting …
In a research report issued this morning, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Omeros Corporation (NASDAQ:OMER) and slightly raised the price …
In a research report issued today, Wedbush analyst Liana Moussatos maintained an Outperform rating on Omeros (NASDAQ:OMER) with a price target of $52, following …
MLV analyst George Zavoico was out pounding the table on Omeros (NASDAQ:OMER) Wednesday, reiterating a Buy rating and a price target of $38.00, which implies …
Out of all of the stocks in the Healthcare sector, biopharmaceutical stocks are some of the most popular due to the revenue potential …
